OWP Pharmaceuticals Revenue and Competitors

Chicago, IL USA

Location

$8M

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • OWP Pharmaceuticals's estimated annual revenue is currently $5.6M per year.(i)
  • OWP Pharmaceuticals's estimated revenue per employee is $201,000
  • OWP Pharmaceuticals's total funding is $8M.

Employee Data

  • OWP Pharmaceuticals has 28 Employees.(i)
  • OWP Pharmaceuticals grew their employee count by 4% last year.

OWP Pharmaceuticals's People

NameTitleEmail/Phone
1
Founder / PresidentReveal Email/Phone
2
Chief Operating OfficerReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
National Business DirectorReveal Email/Phone
6
Senior Director - Commercial OperationsReveal Email/Phone
7
Manager, Contract/Trade OperationsReveal Email/Phone
8
Manager, Corporate OperationsReveal Email/Phone
9
Hybrid Neuroscience Sales SpecialistReveal Email/Phone
10
Inside Sales SpecialistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15.9M7930%N/AN/A
#2
$91.5M4557%N/AN/A
#3
$26.1M13025%$35MN/A
#4
$15.3M76-4%N/AN/A
#5
$6.6M33-25%N/AN/A
#6
$5.6M28-7%N/AN/A
#7
$4.2M21-36%N/AN/A
#8
$10.1M50-25%N/AN/A
#9
$225.5M112219%N/AN/A
#10
$3.2M16-27%N/AN/A
Add Company

What Is OWP Pharmaceuticals?

OWP Pharmaceuticals provides FDA approved epilepsy medications to patients at affordable prices in the United States. We have created a business model that has a significant tie to a “Not for Profit” organization named the ROW Foundation. Through this model both organizations have a vision to drastically improve the lives of epilepsy patients throughout the world including under-resourced patients outside of the United States through increase education, diagnosis and treatment.

keywords:N/A

$8M

Total Funding

28

Number of Employees

$5.6M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$4.8M288%N/A
#2
$5.3M28-7%N/A
#3
$2.9M2961%N/A
#4
$3M290%N/A
#5
$3.5M30-3%N/A